发明名称 METHOD AND OBTAINED HUMAN ANTIBODY OR ITS ANTIGEN-BINDING FRAGMENT FOR INHIBITING HUMAN TNFalpha ACTIVITY, APPLYING THE OBTAINED HUMAN ANTIBODY OR ITS ANTIGEN-BINDING FRAGMENT AS INGREDIENT FOR PRODUCING MEDICAMENT
摘要 FIELD: medicine. ^ SUBSTANCE: obtained human antibody or its antigen-binding fragment specifically binds tumor necrosis factor hTNFalpha. The like antibodies show high affinity relative to hTNFalpha in vitro and in vivo. Antibodies according to the invention are taken as a full-length antibody or its antigen-binding fragment. The antibodies or their fragments are usable for detecting hTNFalpha and for inhibiting hTNFalpha activity in human beings suffering from a disorder in the case of which hTNFalpha activity is harmful. ^ EFFECT: wide range of applications of high affinity recombinant antibodies to hTNFalpha or their fragments of low dissociation kinetics. ^ 15 cl, 11 dwg, 17 tbl
申请公布号 RU2270030(C2) 申请公布日期 2006.02.20
申请号 RU20030120859 申请日期 1997.02.10
申请人 发明人 ALLEN DEBORA DZH.;VOGEN TRISTAN DZH.;KAJMAKSALAN ZERA;MAKGINESS BRAJEN T.;MANKOVICH DZHON EH.;ROBERTS EHNDRJU DZH.;SAKORAFASH POL';SEHLFELD DZHOKHEN G.;UAJT MAJKL;UILTON EHLISON DZH.;KHUGENBUM KHENDRIKUS R. DZH. M.;SHOEHNKHAUT DEHVID;LABKOVSKI BORIS
分类号 A61K39/395;C12N15/09;A61K31/00;A61K31/40;A61K31/403;A61K31/404;A61K31/415;A61K31/4164;A61K31/4178;A61K31/505;A61K31/517;A61K31/52;A61K31/529;A61K31/57;A61K31/573;A61K31/675;A61K38/00;A61K38/04;A61K38/16;A61K39/39;A61P1/00;A61P1/04;A61P1/16;A61P3/10;A61P7/00;A61P7/04;A61P9/00;A61P9/04;A61P9/10;A61P11/00;A61P11/16;A61P13/12;A61P17/00;A61P17/02;A61P19/02;A61P19/06;A61P25/00;A61P27/02;A61P29/02;A61P31/00;A61P31/04;A61P31/12;A61P31/18;A61P33/06;A61P35/00;A61P35/04;A61P37/00;A61P37/02;A61P37/06;A61P37/08;A61P39/02;A61P43/00;C07K16/24;C07K16/46;C12N1/21;C12N5/10;C12N15/13;C12P21/08;G01N33/53;G01N33/543;G01N33/564;G01N33/576;G01N33/68 主分类号 A61K39/395
代理机构 代理人
主权项
地址